Connect with us

Business

Dow Bags Gain on Value Stocks; FDA Approves Gilead’s Anti-Viral Drug – Investing.com

Dow Bags Gain on Value Stocks; FDA Approves Gilead’s Anti-Viral Drug

Published

on

post featured image
ADVERTISEMENT

By Yasin Ebrahim
Investing.com The Dow closed higher Thursday, as value stocks plugged the gap left by a fall in tech stocks on signs of progress on stimulus after House Speaker Nancy Pelosi suggested a deal was close.
Gilead Sciences Inc (NASDAQ:GILD) jumped 4% in after-hours trading after the FDA approved its anti-viral drug.
The Dow Jones Industrial Average rose 0.55%, or 154 points. The S&P 500 was up 0.55%, while the Nasdaq Composite added 0.57%.
Pelosi said a deal on stimulus just about there,”…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
CDC panel to meet Tuesday to vote on COVID-19 vaccine priority – Fox News
post featured image
Tesla could widen release of ‘self-driving’ software in two weeks – Reuters India
post featured image
Shooting reported on West Main in Fort Wayne – WANE